Fortis Malar Hospitals Stock Screener | Share Price & Fundamental Analysis
FORTISMLR
Hospitals
Screen Fortis Malar Hospitals share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹59.12
▼
-0.96 (-1.60%)
Market Cap
₹112.95 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
3.29
EPS (TTM)
₹0.21
Dividend Yield
-
Debt to Equity
-
52W High
₹93.74
52W Low
₹56.42
Operating Margin
-
Profit Margin
-
Revenue (TTM)
₹1.00
EBITDA
-
Net Income
-
Total Assets
₹37.00
Total Equity
₹30.00
Fortis Malar Hospitals Share Price History - Stock Screener Chart
Screen FORTISMLR historical share price movements with interactive charts. Analyze price trends and patterns.
Fortis Malar Hospitals Company Profile - Fundamental Screener
Screen Fortis Malar Hospitals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for FORTISMLR shares.
Sector
Healthcare Services
Industry
Hospitals
Sub-Sector
Hospitals
Segment
E
ISIN
INE842B01015
Fortis Malar Hospitals Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen FORTISMLR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 37 | 116 | 138 | 161 | 169 | 194 | 151 | 149 | 131 | 130 |
| Current Assets | 34 | 113 | 85 | 49 | 60 | 62 | 112 | 113 | 97 | 102 |
| Fixed Assets | 0 | 0 | 47 | 58 | 69 | 81 | 22 | 24 | 25 | 25 |
| Liabilities | ||||||||||
| Total Liabilities | 37 | 116 | 138 | 161 | 169 | 194 | 151 | 149 | 131 | 130 |
| Current Liabilities | 0 | 0 | 42 | 49 | 56 | 62 | 2 | 1 | 1 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 30 | 110 | 64 | 80 | 89 | 96 | 105 | 103 | 100 | 98 |
| Share Capital | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 |
| Reserves & Surplus | 12 | 91 | 45 | 61 | 70 | 78 | 87 | 84 | 81 | 79 |
Screen FORTISMLR income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 5 | 1 | 65 | 1 | 1 | 1 | 23 | 19 | 21 | 19 | 24 | 22 | 25 | 23 |
| Expenses | 0 | 0 | 0 | 5 | 1 | 1 | 0 | 20 | 18 | 18 | 19 | 19 | 20 | 21 | 20 |
| EBITDA | 0 | 4 | 0 | 60 | 0 | 0 | 0 | 3 | 1 | 2 | 0 | 5 | 2 | 4 | 3 |
| Operating Profit % | 0.00% | -1600.00% | -1233.00% | 9.00% | 0.00% | 0.00% | 0.00% | 4.00% | -3.00% | 0.00% | -6.00% | 14.00% | 0.00% | 10.00% | 7.00% |
| Depreciation | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Profit Before Tax | 0 | 4 | 0 | 59 | 0 | 0 | 0 | -2 | -3 | -2 | -4 | 0 | -3 | -1 | -1 |
| Tax | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 1 | 0 | 4 | 0 |
| Net Profit | 0 | 4 | 0 | 54 | 0 | 0 | 0 | -7 | -3 | -2 | -4 | 0 | -3 | -4 | -1 |
| EPS | 0.19 | 2.22 | 0.01 | 28.84 | -0.03 | 0.05 | 0.00 | -3.73 | -1.56 | -0.96 | -2.14 | -0.24 | -1.58 | -2.34 | -0.61 |
Fortis Malar Hospitals Cash Flow Screener - Liquidity Fundamentals
Screen FORTISMLR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 2 | -7 | 6 | 7 | -1 | 0 | -16 | 9 | -9 | 11 |
| Investing Activities | -29 | 120 | 1 | 8 | -28 | 50 | 6 | -2 | 14 | -22 |
| Financing Activities | -80 | -11 | -13 | -10 | -7 | -12 | 0 | 0 | -1 | -1 |
| Net Cash Flow | -107 | 102 | -7 | 5 | -36 | 38 | -10 | 7 | 4 | -13 |
Screen FORTISMLR shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 62.71% | 62.71% | 62.71% | 62.71% | 62.71% | 62.71% | 62.71% | 62.71% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 29.53% | 29.51% | 29.59% | 28.27% | 29.72% | 29.63% | 29.43% | 17.71% |
| Other Holding | 7.69% | 7.71% | 7.63% | 8.95% | 7.50% | 7.59% | 7.79% | 19.51% |
| Shareholder Count | 26,918 | 27,832 | 27,644 | 10,213 | 16,452 | 18,860 | 21,547 | 8,731 |
Fortis Malar Hospitals Dividend Screener - Share Yield Analysis
Screen FORTISMLR dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹42.50 | 57.89% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Fortis Malar Hospitals Index Membership - Market Screener Classification
Screen FORTISMLR by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Fortis Malar Hospitals Market Events Screener - Corporate Actions
Screen FORTISMLR market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-06 | 2025-11-06 | Quarterly Result Announcement | NA | -3.34% |
| 2025-08-04 | 2025-08-04 | Quarterly Result Announcement | NA | 1.66% |
| 2025-07-30 | 2025-07-30 | Annual General Meeting | NA | -6.33% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 8.03% |
| 2025-02-03 | 2025-02-03 | Quarterly Result Announcement | NA | 2.83% |
| 2024-11-05 | 2024-11-05 | Quarterly Result Announcement | NA | 4.06% |
| 2024-07-31 | 2024-07-31 | Annual General Meeting | NA | -0.41% |
| 2024-07-24 | 2024-07-24 | Dividend | ₹ 2.50 /share | -9.97% |
| 2024-04-23 | 2024-04-23 | Dividend | ₹ 40.00 /share | 93.06% |
Fortis Malar Hospitals Competitors Screener - Peer Comparison
Screen FORTISMLR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Max Healthcare Institute | 104,768 | 77.11 | 7,184 | 28.65% | 1,076 | 44.01 |
| Apollo Hospitals | 101,426 | 58.34 | 21,994 | 14.76% | 1,505 | 38.68 |
| Fortis Healthcare | 69,015 | 64.77 | 7,850 | 13.25% | 809 | 52.65 |
| Narayana Hrudayalaya | 38,759 | 46.12 | 5,575 | 12.29% | 790 | 51.11 |
| Global Health | 31,400 | 55.96 | 3,771 | 12.59% | 481 | 42.10 |
| Aster DM Healthcare | 30,942 | 85.02 | 4,287 | 15.12% | 337 | 30.49 |
| Krishna Institute of Medical Sciences | 25,703 | 71.95 | 3,067 | 21.98% | 415 | 35.60 |
| Dr. Agarwal's Health Care | 15,798 | 109.14 | 1,757 | 27.64% | 110 | 47.41 |
| Rainbow Childrens Medicare | 13,802 | 52.87 | 1,567 | 17.46% | 244 | 53.00 |
| Healthcare Global Enterprises | 9,788 | 241.56 | 2,258 | 17.03% | 49 | 40.47 |
Fortis Malar Hospitals Company Announcements - News Screener
Screen FORTISMLR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-07 | Closure of Trading Window | View |
| 2026-01-03 | Status Of Re-Lodgement Of Transfer Requests Of Physical Shares For The Month Ended On November 30 2025 | View |
| 2026-01-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-01-02 | Newspaper Clippings - Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares | View |
| 2025-12-11 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-12-01 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-11-26 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-11-26 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-11-18 | Status Of Re-Lodgement Of Transfer Requests Of Physical Shares For The Months Ended On 30Th October 2025. | View |
| 2025-11-18 | Status Of Re-Lodgement Of Transfer Requests Of Physical Shares For The Months Ended On 30Th October 2025. | View |
| 2025-11-12 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-11-11 | Announcement Made By IHH Healthcare Berhad (IHH) Dated November 11 2025 On The Malaysian Stock Exchange (I.E. Bursa Malaysia) And SGX Stock Exchange Regarding The Completion Of Open Offer. | View |
| 2025-11-11 | Post Offer Advertisement | View |
| 2025-11-10 | Announcement Made By IHH Healthcare Berhad (IHH) Dated November 10 2025 On The Malaysian Stock Exchange (I.E. Bursa Malaysia) And SGX Stock Exchange Regarding The Open Offer | View |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-06 | Un-Audited Financial Results For The Quarter And Half Year Ended On September 30 2025 | View |
| 2025-11-06 | Board Meeting Outcome for Outcome Of Board Meeting For Consideration Of Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-11-01 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-10-28 | Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2025. | View |
| 2025-10-17 | Updates on Open Offer | View |